Introduction. Influenza virus poses significant risks to immunocompromised individuals such
as those who have received organ transplants and are undergoing immunosuppressive …

Background The use of vaccines with higher doses of antigen is an attractive strategy to
improve the immunogenicity of influenza vaccination in transplant recipients. However, the …

Abstract Background/Aims: Although annual influenza vaccination is recommended for
kidney transplant recipients, efficacy as reflected by serum antibody titers has not been well …

Background Data on the immunogenicity (IG) of the influenza vaccine among patients at
high risk of influenza-related complication are limited. Methods We studied the antibody titer …

Context Immunosuppressive regimens increase kidney transplant patients' risk of
contracting life-threatening influenza. However, little information exists about the prevalence …

Background Despite administration of annual influenza vaccination, influenza-associated
complications in transplant recipients continue to be an important cause of hospitalization …

Salles MJC, Sens YAS, Boas LSV, Machado CM. Influenza virus vaccination in kidney
transplant recipients: serum antibody response to different immunosuppressive drugs. Clin …

Whether influenza vaccination in solid-organ transplant recipients is efficacious remains a
controversial issue. Furthermore, theoretical concerns have been raised regarding the safety …

BACKGROUND: Enhancing vaccine immunogenicity in kidney transplant recipients,
particularly against influenza, is required since the immunosuppression used to prevent graft …

Booster influenza vaccination has been recommended for patients with chronic renal
disease in order to enhance the immune response to the influenza vaccine; however, the …